TITLE:
Maternal PAPP-A Levels at 11 - 13 Weeks of Gestation Predict Foetal and Neonatal Growth
AUTHORS:
M. Gentile, M. Schifano, S. Lunardi, C. Nanini, F. Moscuzza, C. Sergiampietri, M. Ciantelli, F. Monacci, A. Boldrini, C. Luchi, P. Ghirri
KEYWORDS:
Maternal Predictors, Foetal Growth, Neonatal Outcome
JOURNAL NAME:
Open Journal of Obstetrics and Gynecology,
Vol.5 No.6,
June
24,
2015
ABSTRACT: Recent reports suggest that maternal serum levels of pregnancy-associated
plasma protein A (PAPP-A) may predict perinatal outcome. PAPP-A is a
syncytiotrophoblast derived protease for insulin-like
growth factor binding protein (IGFBP4); its protease activity cleaves complexed
growth factor binding protein increasing insulin-like growth factor I (IGF-I)
bioavailability. The aim of our study was to evaluate the correlation between
maternal PAPP-A serum levels and neonatal growth. We analysed 100 full term and
preterm (30 - 36 weeks) small for gestational age (SGA) and adequate for
gestational age (AGA) babies whose mothers had been tested for serum PAPP-A at
11 - 13 weeks of gestation. We found a significant positive correlation between
maternal PAPP-A and neonatal weight, length, and head circumference at birth in
both term and preterm infants. Low maternal PAPP-A serum levels (maternal
PAPP-A